<DOC>
	<DOC>NCT00858988</DOC>
	<brief_summary>The purpose of this study is to determine whether rifaximin is effective in the treatment of tropical enteropathy in a population of African children at high risk for this disease.</brief_summary>
	<brief_title>Trial of Rifaximin in the Treatment of Tropical Enteropathy</brief_title>
	<detailed_description />
	<mesh_term>Intestinal Diseases</mesh_term>
	<mesh_term>Sprue, Tropical</mesh_term>
	<mesh_term>Rifaximin</mesh_term>
	<mesh_term>Rifamycins</mesh_term>
	<criteria>live in single village acutely malnourished acutely ill chronic disease</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>5 Years</maximum_age>
	<verification_date>March 2009</verification_date>
</DOC>